25.3 %In the Tunisian cohort of the MEA-WCVD registry, obesity prevalence among women with cardiovascular disease risk factors was 25.3%, compared to 9.4% among men.
TunisieobésitéHAL · Unilimdocument of 95 observations
Explore evidence
Gold tier: mechanically validated evidence, with its primary source.
109 evidence items · page 1 / 5
41.1 %In the Tunisian cohort of the MEA-WCVD registry, CCS presentation among women with coronary heart disease was 41.1%, compared to 32.2% among men.
TunisieCCSHAL · Unilimdocument of 95 observations
34 %Women presented with heart failure with preserved ejection fraction (HFpEF) more frequently than men, with 479 (34%) women versus 388 (15.8%) men.
Tunisieinsuffisance cardiaqueHAL · Unilimdocument of 95 observations
84.7 %In the HFrEF subgroup, beta-blockers were prescribed to 477 (84.7%) women versus 1,269 (85.9%) men.
TunisieHFrEFHAL · Unilimdocument of 95 observations
31.6 %SGLT2 inhibitors were prescribed to 178 women (31.6%) and 530 men (35.9%) in the HFrEF subgroup.
TunisieHFrEFHAL · Unilimdocument of 95 observations
41.1 %In the Tunisian cohort of the MEA-WCVD registry, CCS presentation was more likely in women (41.1%) than in men (32.2%) among those with CHD.
TunisieCCSHAL · Unilimdocument of 95 observations
6.5 daysThe median interval between the date of arrival in Tunisia and symptom onset was 6.5 days.
TunisiepaludismeHAL · Unilimdocument of 123 observations
44.2 %In the Tunisian cohort of the MEA-WCVD registry, diabetes prevalence among women with cardiovascular disease risk factors was 44.2%, compared to 40.5% among men.
Tunisiediabète (non précisé)HAL · Unilimdocument of 95 observations
42.2 %In the Tunisian cohort of the MEA-WCVD registry, NSTEMI presentation among women with coronary heart disease was 42.2%, compared to 40.6% among men.
TunisieNSTEMIHAL · Unilimdocument of 95 observations
51.6 %En Tunisie, une étude rétrospective menée en milieu hospitalier a montré que la fréquence de la neuropathie périphérique diabétique était de 51,6 % chez les diabétiques de type 2 et de 31,8 % chez les diabétiques de type 1.
Tunisieneuropathie périphériqueHAL · Unilimdocument of 747 observations
60 %Dans une étude antérieure menée entre 2002 et 2005 au Tunisie et au Maroc, la prévalence de l'hépatite C chronique était de 60,0 % chez les patients atteints de carcinome hépatocellulaire.
Tunisiecarcinome hépatocellulaire · hépatite Cobserved 2002–2005HAL · Unilimdocument of 199 observations
19 %Women had more hypertensive causes of heart failure (268 women, 19%) compared to men (154 men, 6.3%).
Tunisieinsuffisance cardiaqueHAL · Unilimdocument of 95 observations
38.1 %Women had less ischemic etiology of heart failure than men, with 537 (38.1%) women versus 1,497 (60.9%) men.
Tunisieinsuffisance cardiaqueHAL · Unilimdocument of 95 observations
18 %Dans une étude antérieure menée entre 2002 et 2005 au Tunisie et au Maroc, la prévalence du diabète de type 2 était de 18,0 % chez les patients atteints de carcinome hépatocellulaire.
Tunisiecarcinome hépatocellulaire · diabète de type 2observed 2002–2005HAL · Unilimdocument of 199 observations
25.3 %In the Tunisian cohort of the MEA-WCVD registry, obesity prevalence was significantly higher in women (25.3%) than in men (9.4%).
TunisieobésitéHAL · Unilimdocument of 95 observations
32 %En Tunisie, l'ARN des entérovirus a été détecté chez 32 % des patients atteints de diabète de type 1 (95 personnes), contre 8 % des témoins sains (141 personnes).
Tunisiediabète de type 1 · entérovirusHAL · Unilimdocument of 90 observations
51.6 %En Tunisie, une étude rétrospective menée en milieu hospitalier a montré que la fréquence de neuropathie périphérique diabétique était de 51,6 % chez les diabétiques de type 2.
Tunisiediabète de type 2 · neuropathie périphériqueHAL · Unilimdocument of 747 observations
19.3 %In the Tunisian cohort of the MEA-WCVD registry, absence of diagnosis among women in the acute coronary syndrome setting was 19.3%, compared to 11.7% among men.
Tunisieacute coronary syndromeHAL · Unilimdocument of 95 observations
6.5 daysThe median interval between the date of arrival in Tunisia and symptom onset was 6.5 days (IQR, 3–12), with 84.1% (106/126) of the cases developing the illness within 14 days after arrival and 94.4% (119/126) within 30 days.
TunisiepaludismeHAL · Unilimdocument of 123 observations
17.9 %Dans une étude antérieure menée entre 2002 et 2005 au Tunisie et au Maroc, la prévalence de l'hépatite B chronique était de 17,9 % chez les patients atteints de carcinome hépatocellulaire.
Tunisiecarcinome hépatocellulaire · hépatite Bobserved 2002–2005HAL · Unilimdocument of 199 observations
25.1 %Women presented with heart failure with mid-range ejection fraction (HFmrEF) in 354 cases (25.1%) compared to 570 men (23.3%).
TunisieHFmrEFHAL · Unilimdocument of 95 observations
94.4 %94.4% (119/126) of malaria cases developed illness within 30 days after arrival in Tunisia.
TunisiepaludismeHAL · Unilimdocument of 123 observations
15.8 %Men presented less likely with heart failure with preserved ejection fraction (HFpEF) (388 men, 15.8%) compared to women (479 women, 34%).
TunisieHFpEFHAL · Unilimdocument of 95 observations
42.2 %In the Tunisian cohort of the MEA-WCVD registry, NSTEMI presentation was observed in 42.2% of women and 40.6% of men with CHD.
TunisieNSTEMIHAL · Unilimdocument of 95 observations
40 %Women presented with heart failure with reduced ejection fraction (HFrEF) in 563 cases (40%) compared to 1,477 men (60.3%).
TunisieHFrEFHAL · Unilimdocument of 95 observations
1 / 5next →
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.